SYHA1801 / CSPC Pharma 
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SYHA1801 / CSPC Pharma
NCT04309968: Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA1801 Monotherapy in Patients With Advanced Solid Tumors

Recruiting
1
186
RoW
Drug: SYHA1801
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Advanced Solid Tumors
12/22
06/23

Download Options